Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc. (ticker: ARYB) is the successor entity formed through ARYA Sciences Acquisition Corp II's business combination with Cerevel Therapeutics, a neuroscience-focused biopharmaceutical company originally spun out of Pfizer Inc. in collaboration with Bain Capital. The SPAC, sponsored by ARYA Sciences Management LLC, an affiliate of healthcare-focused investment firm Perceptive Advisors, went public in 2020 targeting the life sciences and biopharma sector. A 10-Q filed with the SEC on August 14, 2020 captures financial disclosures from the period surrounding the announced merger. The combined company subsequently traded on Nasdaq as CERE before being acquired by AbbVie in 2024. Sign up at SpacDesk for full filing histories, deal timelines, and analytics on this and hundreds of other SPAC transactions.